Compartment-specific miRNA-gene expression patterns in relapsing-remitting multiple sclerosis: Clinical blood and...

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• Relapsing-remitting multiple sclerosis (RRMS) involves complex regulatory networks of microRNAs (miRNAs) and target genes.
• The distinct expression patterns of these molecules in blood versus cerebrospinal fluid (CSF) remain incompletely understood.

Purpose of the Study:

• To clinically validate previously identified candidate hub-miRNAs and hub-genes in RRMS.
• To investigate whether expression patterns of these biomarkers differ between blood and CSF compartments in RRMS patients.

Main Methods:

• Experimental validation using ELISA and RT-qPCR for specific miRNAs (hsa-miR-19b-3p, hsa-miR-181c-5p) and genes (ATM, CREB1, ST8SIA4).
• Analysis of paired blood and CSF samples from 30 RRMS patients and 30 controls.
• Statistical analysis including Benjamini-Hochberg FDR correction and group-by-compartment interaction testing.

Main Results:

• Significant differences observed in blood hsa-miR-181c-5p and CSF ATM, CSF hsa-miR-19b-3p, and blood ST8SIA4 protein expression between RRMS patients and controls.
• Significant interactions between blood and CSF compartments were found for ATM, hsa-miR-19b-3p, hsa-miR-181c-5p, and ST8SIA4.
• Exploratory drug-gene analysis identified potential interactions but no evidence of therapeutic efficacy.

Conclusions:

• The study supports compartment-specific dysregulation of miRNA-gene/protein markers in RRMS.
• Blood-CSF expression reversals require confirmation through interaction testing.
• Identified molecules are candidate biomarkers for RRMS, with drug-gene findings being hypothesis-generating.